A
- Abridged Applications
- Advertising and Promotion Advice
- Agency Meetings
- Annual Safety Reports
B
- Biotechnology Advice, Applications
- Bridging Studies and Reports
C
- Centralised Submissions
- Change of Ownership Submissions
- Clinical Overview
- Clinical Summary
- Clinical Trial Applications (CTA)
- CMC (Chemistry, Manufacturing & Control) Reviews
- Common Technical Document (CTD) Formatting and Converting
D
- Decentralised (DCP) submissions
- Dossier Preparation and Review
- Drug Development Advice
- Due Diligence
E
G
- Gap Analysis
- Generics Application
L
- Line extensions
- License/Marketing Authorisation Maintenance
- Literature Surveillance
M
- Manufacturing Rationalisation (Site Transfers)
- Marketing Authorisation Applications
- Mutual Recognition (MRP) Submissions
N
- National Submissions
- NeeS Submissions
- Non-Clinical Overview
- Non-Clinical Summary
O
- On-site Placement & Interim Management
- Orphan Drug Development
P
- Periodic Safety Update Reports (PSUR)
- PIL testing
- Post Marketing Maintenance
Q
- QA/QP Release
- Quality Overall Summary (QOS)
R
- Reclassification (POM - P)
- Regulatory Compliance
- Regulatory Strategy
- Renewals
- Response to Agency Questions
S
- Standard Operating Procedures (SOPs)
- Substantial Amendments to Clinical Trial Applications
- Summary of Product Characteristics (SmPC) Composition
V
- Variations
